Group 1 - The core viewpoint of the news is that 港通医疗 (Kangtong Medical) has shown fluctuations in its stock performance and financial metrics, indicating potential investment opportunities and risks [1][2]. - On February 4, 港通医疗's stock increased by 0.67%, with a trading volume of 73.57 million yuan. The financing data shows a net financing buy of -1.87 million yuan, with a total financing balance of 147 million yuan, which is 8.29% of its market capitalization [1]. - The company has a high financing balance, exceeding the 90th percentile of the past year, indicating a strong interest from investors [1]. - As of January 30, the number of shareholders decreased by 4.48% to 9,164, while the average circulating shares per person increased by 4.69% to 7,155 [2]. Group 2 - For the period from January to September 2025, 港通医疗 reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to shareholders of -10.21 million yuan, a significant decline of 150.92% [2]. - Since its A-share listing, 港通医疗 has distributed a total of 48.99 million yuan in dividends [3]. - As of September 30, 2025, the top ten circulating shareholders include 诺安多策略混合A (Noah Multi-Strategy Mixed A), which holds 725,100 shares as a new shareholder [3].
港通医疗2月4日获融资买入513.41万元，融资余额1.47亿元